GYNAECOLOGY WITH OBSTETRICS

Development of Genital Organs in Humans

Irregularities in the Development of a Woman's Genital Organs

Irregularities can stem from genetic, hormonal, or environmental factors, often termed intersex conditions or disorders of sexual development (DSD). Intersex encompasses conditions where anatomy or chromosomal sex doesn't align with typical male/female definitions.

Complete Androgen Insensitivity Syndrome (CAIS)

In CAIS, individuals with XY chromosomes are resistant to androgens, including testosterone. Despite having testes, external genitalia usually develop as female. The vagina is typically shorter, and there may be an absence or underdevelopment of the uterus and fallopian tubes. Individuals with CAIS typically have female secondary sexual characteristics.

Congenital Adrenal Hyperplasia (CAH)

A group of genetic disorders affecting hormone production in the adrenal glands. The most common form, 21-hydroxylase deficiency, leads to a lack of cortisol and an excess production of androgens. Severe cases may result in external genitalia of female infants appearing masculinized at birth due to high androgen exposure in utero. This condition varies and may involve atypical development of internal reproductive structures.

Mayer-Rokitansky-Küster-Hauser (MRKH) Syndrome

Characterized by the absence or underdevelopment of the uterus and the upper part of the vagina in individuals with normal ovaries and external genitalia. Women with MRKH syndrome typically experience primary amenorrhea (absence of menstruation) and might need surgical intervention to create a functional vagina.

Ovotesticular DSD

This rare condition involves the presence of both ovarian and testicular tissue in the same individual. External genitalia can vary widely and may exhibit ambiguous or atypical characteristics. Surgical interventions may be necessary to address any functional or cosmetic concerns.

Gynatresia

Gynatresia, also known as vaginal atresia or imperforate hymen, is a condition where there is a partial or complete obstruction of the vaginal opening. It is a congenital anomaly that occurs during fetal development when the vaginal canal fails to properly form or the hymen fails to perforate. The vaginal opening may be completely closed or have a very small opening, making it difficult or impossible for menstrual blood and other vaginal secretions to pass through.

Diagnosis

Gynatresia is usually diagnosed during adolescence when a young woman fails to start menstruating or experiences symptoms such as cyclic abdominal pain, cyclic pelvic pain, or a sensation of fullness in the lower abdomen. The condition can vary in severity, with some cases having a thin membrane obstructing the vaginal opening, while others have a complete absence of the vaginal canal.

Treatment

Treatment to correct Gynatresia involves hymenotomy or vaginoplasty.

Sexual Differentiation and Intersexualism

Sexual differentiation is the process by which an embryo develops into a male or female individual with distinct reproductive organs and secondary sexual characteristics. It is a complex process involving genetic, hormonal, and anatomical factors.

Intersexualism describes conditions in which an individual's physical sex characteristics do not conform to typical male or female standards. Intersex conditions can manifest in various ways, affecting chromosomal, gonadal, or anatomical development.

Chromosomal Intersex

Conditions such as Klinefelter syndrome (XXY) and Turner’s syndrome (X0).

Gonadal Intersex

Involves variations in the development of gonads (testes or ovaries). Individuals with partial androgen insensitivity syndrome may have testes but exhibit female or ambiguous external genitalia due to a reduced response to androgens.

Anatomical Intersex

Variations in the external genitalia. Conditions such as ambiguous genitalia or hypospadias (urethral opening on the underside of the penis) can be present, resulting in atypical genital development.

Physiological Concept: Hypothalamus-Pituitary-Ovary (HPO) Axis

The HPO axis plays a crucial role in regulating and maintaining the menstrual cycle and female reproductive functions.

The Hypothalamus

a region in the brain, releases various hormones that act as releasing or inhibiting factors. One of the key hormones it produces is gonadotropin-releasing hormone (GnRH). GnRH travels from the hypothalamus to the pituitary gland through a blood vessel network called the hypothalamic-pituitary portal system.

The Pituitary Gland

Located at the base of the brain, responds to the GnRH signal by releasing two important hormones: follicle-stimulating hormone (FSH) and luteinizing hormone (LH). These hormones are known as gonadotropins. FSH and LH travel through the bloodstream to the ovaries, where they exert their effects. In the ovaries, FSH stimulates the growth and development of ovarian follicles, which contain immature eggs. Within the ovarian follicles, the eggs mature and produce estrogen, a hormone important for various aspects of the menstrual cycle.

Estrogen Feedback

As the ovarian follicles mature, they release increasing amounts of estrogen into the bloodstream. Estrogen exerts negative feedback on the hypothalamus and pituitary gland, reducing the secretion of GnRH, FSH, and LH. When estrogen levels reach a certain threshold, it switches from exerting negative feedback to positive feedback. This positive feedback stimulates the hypothalamus and pituitary gland to increase the secretion of GnRH, FSH, and LH, triggering ovulation.

LH Surge and Ovulation

The LH surge, a rapid and substantial increase in luteinizing hormone, triggers the release of a mature egg from the ovary during ovulation. After ovulation, the follicle that released the egg transforms into the corpus luteum, which produces progesterone. Progesterone prepares the uterus for potential implantation of a fertilized egg.

Fertilization and Implantation

If fertilization and implantation of an embryo occur, the developing embryo releases a hormone called human chorionic gonadotropin (hCG). hCG maintains the corpus luteum, which continues to produce progesterone to support pregnancy. If fertilization does not occur, the corpus luteum degenerates, progesterone levels drop, and menstruation occurs. This marks the beginning of a new menstrual cycle, and the HPO axis starts the process again.

Folliculogenesis

refers to the process of follicle development in the ovaries. It involves the growth, maturation, and release of ovarian follicles. Follicles are fluid-filled structures that contain an immature egg, also known as an oocyte.

Stages of Folliculogenesis

Primordial Follicles

Primordial follicles are the earliest stage of follicle development. These small follicles contain an immature oocyte surrounded by a single layer of flattened cells called granulosa cells. Primordial follicles are present in the ovaries even before birth and represent the pool of potential follicles throughout a woman's reproductive lifespan.

Recruitment

During each menstrual cycle, a few primordial follicles are recruited for further development. This process is initiated by hormonal signals from the hypothalamus and pituitary gland, which stimulate the growth of selected follicles. The recruited follicles begin to grow and develop into primary follicles.

Development of Primary and Secondary Follicles

Primary follicles are characterized by the enlargement of the oocyte and the multiplication of granulosa cells. As the follicle progresses, a fluid-filled space called the antrum begins to form, and the follicle becomes a secondary follicle. The granulosa cells continue to multiply, forming multiple layers around the oocyte.

Tertiary or Antral Follicle

As the secondary follicle further develops, it becomes a tertiary or antral follicle. The antrum expands, and the follicle increases in size. The oocyte continues to mature within the follicle, and a layer of cells called the cumulus oophorus surrounds the oocyte.

Dominant Follicle Selection

In each menstrual cycle, multiple follicles start developing, but usually, only one follicle becomes dominant and continues to grow. The dominant follicle is selected based on hormonal and molecular signals. The other follicles undergo a process called atresia and degenerate.

Ovulation

The dominant follicle, also known as the preovulatory or Graafian follicle, reaches its maximum size and maturity. The follicle wall thins, and a surge in luteinizing hormone (LH) from the pituitary gland triggers ovulation. Ovulation is the release of the mature egg from the ovary, making it available for potential fertilization.

Corpus Luteum Formation

After ovulation, the remaining part of the ruptured follicle transforms into a structure called the corpus luteum. The corpus luteum produces progesterone, a hormone that prepares the uterus for potential implantation of a fertilized egg.

Ovarian Steroidogenesis

Ovarian steroidogenesis refers to the production of steroid hormones within the ovaries. The ovaries are a major source of steroid hormones in females, and they play a vital role in the regulation of various reproductive processes and secondary sexual characteristics.

The two primary classes of steroid hormones produced in the ovaries are estrogens and progestogens, which include progesterone. These hormones are synthesized in specialized cells within the ovaries called theca cells and granulosa cells, which are located in the ovarian follicles.

Steps in Ovarian Steroidogenesis

Cholesterol Uptake

Cholesterol, a precursor molecule for steroid hormones, is obtained from the bloodstream. Theca cells have receptors that allow them to take up cholesterol from circulating lipoproteins.

Conversion to Pregnenolone

Once inside the cells, cholesterol is converted into pregnenolone, a steroid hormone precursor, through a series of enzymatic reactions. This conversion is initiated by the enzyme cholesterol side-chain cleavage enzyme (CYP11A1).

Androgen Production

Pregnenolone is then converted into androgens, primarily androstenedione and testosterone, by the action of enzymes such as 17α17α-hydroxylase (CYP17A1) and 3β3β-hydroxysteroid dehydrogenase (HSD3B). Theca cells are the primary site of androgen production within the ovaries.

Estrogen Production

Androgens produced by theca cells are transported to neighboring granulosa cells. Granulosa cells possess the enzyme aromatase (CYP19A1), which converts androgens into estrogens, predominantly estradiol (the most potent estrogen). Estrogens are important for the development and maintenance of female reproductive structures and secondary sexual characteristics.

Progesterone Production

After ovulation, the remaining cells of the ruptured ovarian follicle form a temporary structure called the corpus luteum. The corpus luteum is responsible for progesterone production. Granulosa cells within the corpus luteum undergo changes, and they produce progesterone, which is important for preparing the uterus for potential implantation of a fertilized egg and supporting early pregnancy.

Ovulation

Ovulation is the process by which a mature egg (also known as an oocyte) is released from the ovary and becomes available for fertilization.

The surge in LH causes the dominant follicle to rupture, and the mature egg is released from the ovary. The egg is swept into the fallopian tube, where it awaits fertilization by sperm.

Yellow Body – Corpus Luteum

After the egg is released, the remaining part of the follicle within the ovary undergoes changes and transforms into a structure called the corpus luteum. The corpus luteum produces progesterone, which is important for preparing the uterus for potential implantation of a fertilized egg by promoting the thickening of the uterine lining (endometrium) and creating a favorable environment for implantation of a fertilized egg.

If fertilization and implantation occur, the developing embryo releases a hormone called human chorionic gonadotropin (hCG). hCG signals the corpus luteum to continue producing progesterone, ensuring the continued support of the uterine lining and early pregnancy. The corpus luteum can persist and produce progesterone for several weeks until the placenta takes over hormone production.

If fertilization does not occur, the corpus luteum gradually regresses and undergoes structural and functional changes. The production of progesterone declines, leading to a decrease in the thickness of the uterine lining. Eventually, the corpus luteum transforms into a small, scar-like structure called the corpus albicans.

Menstrual Cycle

It involves a series of hormonal and physiological changes that prepare the body for potential pregnancy. The menstrual cycle typically lasts about 28 days, although it can vary from person to person.

Phases of the Menstrual Cycle

Menstruation (Days 1-5)

The menstrual cycle begins with menstruation, also known as the menstrual period. During this phase, the uterus sheds its lining, resulting in the discharge of blood and tissue through the vagina. The average duration of menstrual bleeding is around 3 to 5 days, but it can vary.

Follicular Phase (Days 1-14)

Following menstruation, the follicular phase begins. It starts on the first day of menstruation and lasts until ovulation. During this phase, the pituitary gland releases follicle-stimulating hormone (FSH), which stimulates the growth and maturation of ovarian follicles. One dominant follicle usually emerges, and as it grows, it produces estrogen, which thickens the uterine lining (endometrium) in preparation for potential implantation.

Ovulation (around Day 14)

Ovulation is the process in which a mature egg (oocyte) is released from the ovary and becomes available for fertilization. It occurs approximately in the middle of the menstrual cycle, around day 14 in a 28-day cycle. Ovulation is triggered by a surge in luteinizing hormone (LH) from the pituitary gland, which stimulates the release of the egg from the ovary

Luteal Phase (Days 15-28)

After ovulation, the luteal phase begins. During this phase, the ruptured ovarian follicle transforms into a temporary endocrine structure called the corpus luteum. The corpus luteum produces progesterone, which prepares the uterine lining for potential implantation of a fertilized egg. If pregnancy occurs, the corpus luteum continues to produce progesterone to support the early stages of pregnancy. If pregnancy does not occur, the corpus luteum regresses, leading to a decrease in progesterone levels.

If fertilization and implantation do not occur, the corpus luteum regresses, resulting in a drop in hormone levels. The uterine lining is shed during menstruation, and the menstrual cycle begins again with a new cycle of follicular development.

Stages in Formation of Blastocyst

The development of an embryo from a zygote to a blastocyst involves several stages. Here's an overview of these stages:

Zygote Formation

The zygote is formed when a sperm cell fertilizes an egg cell during fertilization. This results in the fusion of their genetic material, creating a single-celled embryo called a zygote.

Cleavage

The zygote undergoes a series of cell divisions known as cleavage. During cleavage, the zygote rapidly divides into smaller cells called blastomeres. These divisions do not increase the overall size of the embryo; instead, the cells become progressively smaller with each division.

Morula

As cleavage continues, the embryo transforms into a solid ball of cells called a morula. The morula consists of multiple blastomeres and resembles a raspberry in appearance.

Blastocyst Formation

Further cell divisions lead to the formation of a blastocyst. The blastocyst is a fluid-filled structure composed of two distinct cell types: the outer trophoblast cells and the inner cell mass (ICM).

Trophoblast

The trophoblast cells will later give rise to the placenta and play a crucial role in implantation.

Inner Cell Mass (ICM)

The ICM is a cluster of cells within the blastocyst that will eventually develop into the embryo proper.

Blastocyst Hatching

The blastocyst continues to develop and grows in size. It eventually undergoes a process called hatching, where it breaks free from the zona pellucida (the protective shell around the embryo) in preparation for implantation into the uterine lining.

Implantation

The blastocyst travels through the fallopian tube and reaches the uterus, where it attaches to the thickened uterine lining (endometrium) in a process known as implantation. Implantation allows the embryo to establish a connection with the maternal blood supply for nutrient exchange and further development.

Gastrulation and Germ Layer Formation

After implantation, the embryo undergoes gastrulation, during which the three primary germ layers (ectoderm, mesoderm, and endoderm) form. These layers give rise to various tissues and organs in the developing embryo.

Ovarian Cycle

Ovarian cycle refers to the cyclic changes that occur in the ovaries as part of the menstrual cycle. It involves the growth and development of ovarian follicles, ovulation, and the formation and regression of the corpus luteum.

The ovarian cycle consists of two main phases:

Follicular phase

The follicular phase begins on the first day of the menstrual cycle and extends until ovulation. During this phase, follicles in the ovaries start to develop under the influence of follicle-stimulating hormone (FSH) released by the pituitary gland. These follicles contain immature eggs (oocytes) surrounded by granulosa cells. Only one follicle usually becomes the dominant follicle, while the others undergo degeneration. The dominant follicle continues to grow and produce increasing amounts of estrogen. The estrogen stimulates the thickening of the uterine lining (endometrium) in preparation for potential implantation.

Luteal phase

The luteal phase follows ovulation and lasts until the start of the next menstrual cycle. After ovulation, the dominant follicle transforms into the corpus luteum. The corpus luteum produces progesterone, which further prepares the endometrium for potential implantation and helps maintain pregnancy if fertilization occurs. If fertilization and implantation do not occur, the corpus luteum regresses, progesterone levels decrease, and the endometrium begins to shed, resulting in menstruation.

The hormonal interactions between the hypothalamus, pituitary gland, and ovaries regulate the ovarian cycle.

Endometrial cycle

refers to the cyclic changes that occur in the endometrium (the inner lining of the uterus) in response to hormonal fluctuations.

Phases of the Endometrial Cycle

Menstrual Phase

The menstrual phase marks the beginning of the cycle and is characterized by the shedding of the endometrium. It occurs when there is a decrease in the levels of estrogen and progesterone due to the regression of the corpus luteum. The shedding of the endometrial tissue results in menstrual bleeding, which typically lasts for a few days.

Proliferative Phase

After the menstrual phase, the endometrium begins to regenerate and thicken under the influence of estrogen. The proliferative phase is characterized by the growth and development of the endometrial tissue, including the proliferation of glandular cells and an increase in blood vessel formation. The endometrium becomes thicker and more vascularized, preparing for potential implantation of a fertilized egg.

Secretory Phase

The secretory phase occurs after ovulation and is primarily driven by progesterone produced by the corpus luteum. Progesterone causes the endometrium to become more glandular and vascular, preparing it for embryo implantation. The glands in the endometrium secrete nutrients and other substances that support early pregnancy. If fertilization and implantation occur, the secretory phase continues to support the developing embryo. If fertilization does not occur, the corpus luteum regresses, progesterone levels drop, and the secretory endometrium undergoes degeneration.

These phases of the endometrial cycle are regulated by the interplay of estrogen and progesterone, which are produced by the ovaries in response to hormonal signals from the hypothalamus and pituitary gland

Menstruation

Menstruation refers to the monthly shedding of the uterine lining (endometrium) in females of reproductive age who are not pregnant. Menstruation involves the discharge of blood, mucus, and tissue from the uterus through the vagina. The blood comes from small blood vessels in the endometrium that break down as the lining is shed.
symptoms and discomfort associated with menstruation, such as abdominal cramps (dysmenorrhea), bloating, breast tenderness, mood changes, and fatigue.

Ovulation Tests

Ovulation tests are used by women to predict when they are ovulating. Ovulation is the process in which a mature egg is released from the ovary and is available for fertilization by sperm. By detecting the surge in luteinizing hormone (LH) levels that occurs just before ovulation, ovulation tests help women identify their fertile window.

Ovulation tests usually come in the form of urine test strips or digital devices. They detect the presence of LH, a hormone that surges in concentration about 24-36 hours before ovulation.

a positive result is indicated by a test line that is as dark or darker than the control line. This suggests that ovulation is likely to occur within the next 24-36 hours. It's important to note that a positive result doesn't guarantee that ovulation will definitely occur, but it indicates that it's likely.

Once you detect a positive result, it's recommended to have intercourse in the following days to maximize the chances of conception. You can also track other signs of ovulation, such as changes in cervical mucus consistency or using a basal body temperature (BBT) chart, to further confirm ovulation.

Disorders of the Menstrual Cycle

Amenorrhea

This is the absence of menstruation. Primary amenorrhea refers to a condition in which a woman has not started menstruating by the age of 16, while secondary amenorrhea occurs when a woman who previously had regular periods stops menstruating for at least three cycles.

Amenorrhea can be caused by various factors such as hormonal imbalances, pregnancy, breastfeeding, excessive exercise, stress, polycystic ovary syndrome (PCOS), and certain medical conditions.

Dysmenorrhea

Dysmenorrhea refers to painful menstrual periods. Primary dysmenorrhea is the most common type and is not caused by an underlying condition. It is typically characterized by cramping pain in the lower abdomen, which may be accompanied by other symptoms such as nausea, vomiting, headache, and fatigue.

Secondary dysmenorrhea occurs as a result of an underlying condition, such as endometriosis, uterine fibroids, or pelvic inflammatory disease.

Menorrhagia

Menorrhagia refers to abnormally heavy or prolonged menstrual bleeding. Women with menorrhagia may experience prolonged periods (more than seven days) or need to change sanitary pads or tampons every hour or two.

Causes of menorrhagia can include hormonal imbalances, uterine fibroids, polyps, adenomyosis, blood clotting disorders, and certain medications.

Polycystic Ovary Syndrome (PCOS)

PCOS is a hormonal disorder that affects women of reproductive age. It is characterized by the presence of multiple cysts on the ovaries, irregular periods or amenorrhea, excessive hair growth, acne, and obesity.

PCOS is associated with hormonal imbalances, particularly high levels of androgens (male hormones), and insulin resistance.

Premenstrual Syndrome (PMS)

PMS refers to a combination of physical and emotional symptoms that occur in the days or weeks before menstruation. Symptoms can include mood swings, irritability, bloating, breast tenderness, fatigue, and food cravings.

Severe PMS, known as premenstrual dysphoric disorder (PMDD), is a more severe form that significantly affects a woman's quality of life.

Premature Ovarian Insufficiency (POI)

POI, also known as premature menopause or early ovarian failure, is a condition in which a woman's ovaries stop functioning before the age of 40. It can lead to irregular or absent periods, infertility, and symptoms associated with menopause, such as hot flashes, vaginal dryness, and mood changes.

Amenorrhea - Diagnostic procedures

Amenorrhea is the absence of menstruation.

Primary Amenorrhea

Primary amenorrhea occurs when you haven’t had a period by 15 years old. Common causes include:

  • Chromosomal or genetic problems that affect your reproductive system, such as Turner syndrome.

  • Hormonal issues stemming from problems with your brain or pituitary gland.

  • Structural problems with your organs, such as missing parts of your uterus or vagina or having an underdeveloped reproductive system.

Secondary Amenorrhea

Secondary amenorrhea is when you miss your period for three or more months after previously having a normal period. Common causes include:

  • Some birth control methods, such as Depo-Provera®, intrauterine devices (IUDs) and certain birth control pills.

  • Chemotherapy and radiation therapy for cancer.

  • Previous uterine surgery with scarring (for example, if you had a dilation and curettage, often called D&C).

  • Stress.

  • Poor nutrition.

  • Weight changes — extreme weight loss or gain.

  • Extreme exercise routines.

  • Certain medications.

Diagnostic procedures

  • Medical history and physical examination

  • Hormonal blood tests

    • Estradiol: This is the primary form of estrogen, and its levels can indicate ovarian function.

    • Prolactin: High levels of prolactin, a hormone that stimulates milk production, can disrupt normal menstrual cycles.

    • Thyroid-stimulating hormone (TSH) and thyroid hormones: Thyroid disorders can contribute to menstrual irregularities

    • FSH, LH

  • Imaging tests

    • Pelvic ultrasound: This test uses sound waves to create images of the pelvic organs, such as the uterus and ovaries, to check for structural abnormalities.

    • MRI or CT scan

  • Genetic testing

  • Pregnancy test

Uterine Amenorrhea

Ovarian Amenorrhea

Ovarian amenorrhea refers to the absence of menstruation due to dysfunction or failure of the ovaries. It is also known as "ovarian insufficiency" or "ovarian failure."

Ovarian amenorrhea can have various causes, including:

  • Premature Ovarian Insufficiency (POI):

    This condition occurs when the ovaries stop functioning before the age of 40. It can be caused by genetic factors, autoimmune disorders, chemotherapy or radiation therapy, certain infections, or unknown reasons.

  • Polycystic Ovary Syndrome (PCOS):

    PCOS is a hormonal disorder in which the ovaries produce higher-than-normal levels of androgens (male hormones). This hormonal imbalance can disrupt ovulation and lead to irregular or absent periods.

  • Ovarian surgery or removal:

    Surgical interventions involving the ovaries, such as oophorectomy (removal of one or both ovaries) or ovarian cystectomy (removal of ovarian cysts), can result in ovarian amenorrhea.

  • Chromosomal abnormalities:

    Certain chromosomal disorders, such as Turner syndrome, can cause ovarian dysfunction and lead to amenorrhea.

  • Other factors:

    Certain medications, stress, extreme weight loss or gain, excessive exercise, and certain medical conditions can also contribute to ovarian amenorrhea.

Pituitary Amenorrhea

Pituitary amenorrhea refers to the absence of menstruation due to dysfunction or disruption of the pituitary gland

Pituitary amenorrhea can have several causes, including:

  • Stress and emotional factors:

    Chronic stress, emotional trauma, or excessive exercise can disrupt the functioning of the hypothalamus and pituitary gland, leading to amenorrhea.

  • Excessive exercise:

    Intense exercise, particularly when combined with inadequate caloric intake, can cause hormonal imbalances that result in amenorrhea

  • Hormonal imbalances:

    Certain hormonal imbalances, such as high levels of prolactin (hyperprolactinemia), can interfere with the release of hormones necessary for ovulation and menstruation.

  • Tumors or abnormalities:

    Rarely, tumors or abnormalities in the pituitary gland or hypothalamus can disrupt hormone production and lead to amenorrhea.

Hypothalamic Amenorrhea

Hypothalamic amenorrhea refers to the absence of menstruation due to dysfunction or disruption of the hypothalamus, a part of the brain that plays a crucial role in regulating the menstrual cycle

Sy PCO – Polycystic Ovary Syndrome

Idiopathic is a hormonal disorder that affects women of reproductive age. It is characterized by the presence of multiple small cysts on the ovaries, irregular menstrual cycles, and symptoms related to hormonal imbalances.

Common features and symptoms of PCOS include

  • Menstrual irregularities:

    PCOS often causes irregular menstrual cycles, which may be characterized by infrequent periods, prolonged periods, or unpredictable bleeding patterns.

  • Hyperandrogenism:

    Women with PCOS may have higher levels of androgens (male hormones) in their bodies, leading to symptoms such as excessive hair growth (hirsutism), acne, and male-pattern baldness.

  • Polycystic ovaries:

    PCOS is characterized by the presence of multiple small cysts on the ovaries. However, not all women with PCOS have visible cysts, and the term "polycystic" refers to the appearance of the ovaries on an ultrasound rather than the presence of actual cysts.

  • Insulin resistance:

    Many women with PCOS have insulin resistance, which means their bodies have difficulty using insulin effectively. Insulin resistance can lead to high insulin levels, which in turn can disrupt hormone production and contribute to PCOS symptoms.

  • Metabolic abnormalities:

    PCOS is associated with an increased risk of metabolic disorders, such as obesity, type 2 diabetes, high cholesterol levels, and high blood pressure.

Diagnosis of PCOS

  • Medical history and physical examination:

    The healthcare provider will inquire about menstrual history, symptoms, and perform a physical examination to check for signs of PCOS, such as hirsutism or acne.

  • Hormonal blood tests:

    Elevated androgen levels and abnormal ratios of LH to FSH are often observed in PCOS.

  • Pelvic ultrasound: A transvaginal ultrasound may be performed to examine the ovaries for the presence of multiple small cysts and to evaluate the ovarian size and appearance.

Treatment of PCOS

  • Lifestyle modification

  • Medications:

    Hormonal birth control pills or other hormonal medications may be prescribed to regulate menstrual cycles, reduce androgen levels, and improve symptoms such as hirsutism and acne. Other medications, such as anti-androgens and insulin-sensitizing agents, may also be used in specific cases.

  • Fertility treatment:

    Women with PCOS who are trying to conceive may require additional fertility treatments, such as ovulation induction with medications or assisted reproductive technologies

Dysmenorrhea

Dysmenorrhea refers to painful menstrual periods. Primary dysmenorrhea is the most common type and is not caused by an underlying condition.

It is typically characterized by cramping pain in the lower abdomen, which may be accompanied by other symptoms such as nausea, vomiting, headache, and fatigue.

Secondary dysmenorrhea occurs as a result of an underlying condition, such as endometriosis, uterine fibroids, or pelvic inflammatory disease.

Premenstrual Tension Syndrome

Refers to a group of physical and emotional symptoms that occur in the days or weeks leading up to menstruation

Physical Symptoms

  • Breast tenderness or swelling

  • Bloating or weight gain

  • Fatigue or low energy levels

  • Headaches or migraines

  • Muscle aches or joint pain

  • Changes in appetite or food cravings

Emotional and psychological symptoms

  • Mood swings or irritability

  • Anxiety or depression

  • Feeling overwhelmed or out of control

  • Difficulty concentrating or focusing

  • Increased sensitivity to stress or emotional triggers

Diagnosis

Is based on a thorough assessment of symptoms and their timing in relation to the menstrual cycle

Treatment

  • Regular exercise

  • Medication

    • Nsaids (pain)

    • SSRIs (antidepressants)

Metrorrhagia

Metrorrhagia refers to abnormal uterine bleeding that occurs between menstrual periods. It is characterized by irregular, unpredictable, and often prolonged or heavy bleeding that can occur at any time during the menstrual cycle. Bleeding that exceeds normal menstrual flow, with periods lasting longer than seven days or requiring frequent changes of pads or tampons.

Causes

  • Hormonal imbalances:

    Fluctuations in hormone levels, particularly estrogen and progesterone, can disrupt the normal menstrual cycle and lead to irregular bleeding. Conditions such as polycystic ovary syndrome (PCOS), thyroid disorders, or changes in hormonal contraception can contribute to hormonal imbalances.

  • Uterine fibroids:

    These are noncancerous growths that develop in or on the uterus. Fibroids can cause abnormal bleeding patterns, including metrorrhagia, due to their impact on the uterine lining.

  • Uterine polyps:

    These are small, benign growths that occur on the inner lining of the uterus. Polyps can cause irregular bleeding, including metrorrhagia, when they interfere with the normal shedding of the uterine lining.

  • Endometrial hyperplasia:

    This condition involves the excessive thickening of the uterine lining. It can result from hormonal imbalances or prolonged exposure to estrogen without the balancing effects of progesterone, leading to abnormal bleeding patterns.

  • Infections or inflammation:

    Infections of the reproductive organs, such as pelvic inflammatory disease (PID) or sexually transmitted infections (STIs), can cause inflammation and lead to abnormal bleeding.

  • Certain medications or medical conditions:

    Some medications, such as anticoagulants or hormonal therapies, can cause metrorrhagia as a side effect. Additionally, certain medical conditions, such as bleeding disorders or liver disease, can contribute to abnormal bleeding.

Diagnosis

Involves a thorough medical history, physical examination, and possibly additional tests, which may include blood tests to check hormone levels, ultrasound imaging to evaluate the uterus and ovaries, or a biopsy of the uterine lining.

Treatment

  • Hormonal therapies

  • Non Hormonal medications:

    Nonsteroidal anti-inflammatory drugs (NSAIDs) can help reduce heavy bleeding and alleviate pain associated with metrorrhagia.

  • Surgical interventions:

    If the cause of metrorrhagia is related to uterine fibroids, polyps, or endometrial hyperplasia, surgical procedures such as hysteroscopy or endometrial ablation may be recommended.

Menorrhagia

Menorrhagia: Bleeding that exceeds normal menstrual flow, with periods lasting longer than seven days or requiring frequent changes of pads or tampons.

Clinical Features

  • Excessive bleeding:

    Menstrual flow that is significantly heavier than usual, requiring frequent pad or tampon changes (more than one pad or tampon per hour).

  • Prolonged periods:

    Menstrual periods that last longer than seven days

  • Passing large blood clots:

    The presence of blood clots larger than a quarter in size during menstruation.

  • Anemia symptoms:

    Symptoms of anemia, such as fatigue, weakness, or shortness of breath, which can result from excessive blood loss.

Causes

  • Hormonal imbalances:

    Hormonal fluctuations, particularly an imbalance between estrogen and progesterone, can affect the normal shedding of the uterine lining during menstruation and lead to excessive bleeding.

  • Uterine fibroids:

    Noncancerous growths in the uterus can cause heavy or prolonged bleeding if they are located within or near the uterine lining.

  • Adenomyosis:

    This condition occurs when the tissue lining the uterus grows into the muscular wall of the uterus, leading to heavy or prolonged bleeding and menstrual pain.

  • Endometrial polyps:

    Small growths on the inner lining of the uterus can cause menorrhagia by interfering with the normal shedding of the uterine lining.

  • Endometrial hyperplasia:

    Excessive thickening of the uterine lining can result in heavy or prolonged bleeding during menstruation.

  • Blood clotting disorders

  • Certain medications or medical conditions

Diagnosis and Treatment

Diagnosis & Treatment are the same as metorrhagia

Dysfunctional Uterine Bleeding

A term used to describe abnormal uterine bleeding that does not have an identifiable structural or hormonal cause

Causes

  • Hormonal imbalances: Fluctuations in estrogen and progesterone levels,

  • Anovulation: Lack of ovulation, where an egg is not released from the ovary, can result in hormonal imbalances and dysfunctional bleeding.

  • Uterine factors: Such as uterine fibroids or polyps, can contribute to abnormal bleeding patterns.

  • Blood clotting disorders

  • Medications or medical conditions

Dianosis, treatment same as meno and meto

Puberty

Puberty is the period of sexual maturation and physical growth that occurs in children as they transition into adolescence. Typically it occurs between ages 8-14 in girls, 9-15 in boys.

Puberty Disorders

Hypogonadism

Refers to a condition in which the gonads (ovaries in females or testes in males) do not produce enough sex hormones, resulting in impaired sexual development and reproductive function. It can be classified as